Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial
Open Access
- 27 February 2019
- journal article
- research article
- Published by Springer Nature in Spinal Cord
- Vol. 57 (7) , 550-561
Abstract
Study design Randomised double-blind factorial-design placebo-controlled trial. Objective Urinary tract infections (UTIs) are common in people with spinal cord injury (SCI). UTIs are increasingly difficult to treat due to emergence of multi-resistant organisms. Probiotics are efficacious in preventing UTIs in post-menopausal women. We aimed to determine whether probiotic therapy with Lactobacillus reuteri RC-14+Lactobacillus GR-1 (RC14-GR1) and/or Lactobacillus rhamnosus GG+Bifidobacterium BB-12 (LGG-BB12) are effective in preventing UTI in people with SCI. Setting Spinal units in New South Wales, Australia with their rural affiliations. Methods We recruited 207 eligible participants with SCI and stable neurogenic bladder management. They were randomised to one of four arms: RC14-GR1+LGG-BB12, RC14-GR1+placebo, LGG-BB12+ placebo or double placebos for 6 months. Randomisation was stratified by bladder management type and inpatient or outpatient status. The primary outcome was time to occurrence of symptomatic UTI. Results Analysis was based on intention to treat. Participants randomised to RC14-GR1 had a similar risk of UTI as those not on RC14-GR1 (HR 0.67; 95% CI: 0.39–1.18; P = 0.17) after allowing for pre-specified covariates. Participants randomised to LGG-BB12 also had a similar risk of UTI as those not on LGG-BB12 (HR 1.29; 95% CI: 0.74–2.25; P = 0.37). Multivariable post hoc survival analysis for RC14-GR1 only vs. the other three groups showed a potential protective effect (HR 0.46; 95% CI: 0.21–0.99; P = 0.03), but this result would need to be confirmed before clinical application. Conclusion In this RCT, there was no effect of RC14-GR1 or LGG-BB12 in preventing UTI in people with SCI.Keywords
Funding Information
- National Health and Medical Research Council (630448, 630448, 630448, 630448, 630448, 630448, 630448, 630448, 630448, 630448, 630448, 630448, 630448, 630448)
This publication has 23 references indexed in Scilit:
- Lactobacilli vs Antibiotics to Prevent Urinary Tract InfectionsArchives of internal medicine (1960), 2012
- International standards for neurological classification of spinal cord injury (Revised 2011)The Journal of Spinal Cord Medicine, 2011
- Bladder Management After Spinal Cord Injury in the United States 1972 to 2005Journal of Urology, 2010
- Spinal-injured neuropathic bladder antisepsis (SINBA) trialSpinal Cord, 2006
- Probiotics for Prevention of Recurrent Urinary Tract Infections in WomenDrugs, 2006
- Current Implications of Drug Resistance in Spinal Cord InjuryAmerican Journal of Physical Medicine & Rehabilitation, 2003
- Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in womenBMJ, 2001
- Interference in Initial Adhesion of Uropathogenic Bacteria and Yeasts to Silicone Rubber by A Lactobacillus Acidophilus BiosurfactantJournal of Medical Microbiology, 1998
- Urinary tract infection in persons with spinal cord injuryArchives of Physical Medicine and Rehabilitation, 1995
- Epidemiology and risk factors for urinary tract infection following spinal cord injuryArchives of Physical Medicine and Rehabilitation, 1993